May 22, 2025

FDA to Rethink COVID Booster Formula

FDA advisers to vote on whether 2025–2026 COVID vaccines should target JN.1 descendants like LP.8.1 amid rising uncertainty over dominant strains.

Reuters

May 22, 2025

FDA Approves Mepolizumab for Eosinophilic COPD

Nucala gains FDA approval to treat chronic obstructive pulmonary disease, expanding its use to patients with eosinophilic inflammation.

Conexiant

May 22, 2025

Dual Inhaler Halves Mild Asthma Attacks in Trial

As-needed albuterol-budesonide was superior to albuterol alone for mild, uncontrolled asthma in new trial.

Conexiant

May 20, 2025

New COVID Shot: LP.8.1?

FDA advisers to consider recommending COVID-19 vaccine for 2025-2026 season to target LP.8.1 subvariant.

Reuters

May 20, 2025

No Trials, No Boosters, Says FDA

FDA to require new clinical trials for COVID booster approval in healthy Americans under 65, limiting fall availability to high-risk groups.

Reuters

May 19, 2025

Protein-Based COVID Vaccine Gains FDA Approval

The FDA has approved the first recombinant protein-based, non-mRNA COVID-19 vaccine.

Conexiant

May 19, 2025

Zyrtec and Xyzal: FDA Issues Withdrawal Syndrome Warning

A new safety alert highlights the potential for severe itch following discontinuation of long-term cetirizine and levocetirizine use.

Conexiant

May 19, 2025

Bacteria Eat, Exploit Plastic: Study 

A hospital-derived strain of Pseudomonas aeruginosa was found to degrade medical plastic, use it as food, and form stronger biofilms, revealing new risks for device-related infections.

Conexiant

May 14, 2025

FDA OKs AbbVie's Targeted Lung Drug

The FDA has approved AbbVie's Emrelis, a targeted therapy for advanced non-small cell lung cancer with high c-Met expression.

Reuters